For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from potentially dangerous substances and microbes. They struggled with a number of parameters, such as blood flow and binding to plasma proteins, which were shown to impact permeability in different ways.